Clinical trials
Phase 4 Postpartum Hemorrhage trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 6 |
| 2015 | 2 |
| 2016 | 8 |
| 2017 | 1 |
| 2018 | 11 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 35 |
| Unknown status | 11 |
| Recruiting | 5 |
| Withdrawn | 4 |
| Terminated | 3 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cairo University | 5 |
| Gynuity Health Projects | 4 |
| Assiut University | 3 |
| Beni-Suef University | 3 |
| Talkha Central Hospital | 2 |
| Al-Kindy College of Medicine | 1 |
| Ankara Etlik City Hospital | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Assuta Ashdod Hospital | 1 |
| Aswan University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Postpartum Hemorrhage | 59 |
| Uterine Inertia | 10 |
| Hemorrhage | 6 |
| Anemia | 4 |
| Blood Loss, Surgical | 4 |
| Hemostatic Disorders | 3 |
| Agnosia | 2 |
| Pain | 2 |
| Postoperative Hemorrhage | 2 |
| Postoperative Pain | 2 |
Trials
Showing 26 to 50 of 59. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.